Featured In Cardiovascular
Massachusetts General Hospital specialists collaborate to identify problems earlier in people with diabetes and peripheral artery disease, improving chances of limb preservation.
Featured In Research and Innovation
Jehan W. Alladina, MD, and Benjamin D. Medoff, MD, of the Division of Pulmonary and Critical Care Medicine, and colleagues advise that high plasma concentrations of soluble suppression of tumorigenicity-2 may signify persistent lung injury in COVID-19 respiratory failure and the need for continued ventilatory support.
Featured In Orthopaedics
U.S. Minority Groups Have Worse Outcomes Than White Patients After Revision Total Hip and Knee Joint Arthroplasty
Christian Klemt, PhD, Anand Padmanabha, MD, Young-Min Kwon, MD, PhD, and colleagues have determined that utilization of revision total hip and knee joint arthroplasty (TJA) in racial/ethnic minorities is worse than for primary TJA, and a number of post-revision outcomes are significantly worse than for white patients.
The study involves multiple visits over 6 months. You will complete an 8-week stress reduction treatment that includes a medical device worn in the ear and attend MRI and PET scans. You will also complete daily migraine diaries online.
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
We are looking for adults 55-80 years old with Alzheimer's Disease to receive infusions of an experimental drug, JNJ-63733657, or a placebo (inactive) infusion. This study will help us determine the safety and efficacy of JNJ-63733657.